Company Overview
Snapshot
Founded in January 2020 by Dean Bitan, Shahar Porat, and Jonathan Zalach, Imagene operates with 11–50 employees. The company has raised $44.5M across 3 funding rounds from 6 investors. In July 2025, Imagene secured Series B funding, with Larry Ellison participating.
Business overview
Imagene leverages AI to profile a broad range of biomarkers from biopsy images in real-time, aiming to democratize precision medicine for cancer patients. The company's technology classifies patterns invisible to the human eye, integrating genomics, proteomics, and spatial insights for rapid and accurate molecular profiling. Imagene serves the healthcare and life sciences sectors, including pharmaceutical companies, hospitals, and healthcare providers, by enabling better patient stratification for clinical trials and the discovery of novel drug targets. Its core products include the Oncology Intelligence Foundation Model, LungOI, and CanvOI, operating within the Digital Healthcare and Digital Medical Diagnostics categories.
Strategic signal
In September 2024, Imagene launched its CanvOI model, powered by Oracle Cloud, to advance cancer treatment. This initiative signals a strategic collaboration with a major technology provider to scale its AI capabilities and accelerate the development of its oncology intelligence platform, indicating a strong focus on leveraging cloud infrastructure for broader market reach and enhanced diagnostic precision.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent funding event for Imagene?
- In July 2025, Imagene secured Series B funding, with Larry Ellison leading the round.
- What is Imagene's total capital raised and number of funding rounds?
- Imagene has raised a total of $44.5M across 3 funding rounds. The most recent was a Series B round in July 2025, led by Larry Ellison, and a Series A round in May 2022, led by Eyal Gura, Dr. David Agus, and Larry Ellison.
- What new product did Imagene announce in September 2024?
- In September 2024, Imagene launched the CanvOI model, powered by Oracle Cloud, to advance cancer treatment.
- What award did Imagene win in October 2023?
- In October 2023, Imagene won the 2023 Digital Health Awards for "Best use of AI in Health Tech".
- What was a key commercialization step for Imagene's LungOI product in May 2024?
- In May 2024, Imagene advanced LungOI commercialization with a new payment code and pricing, complementing its prior CLIA Certified US Lab.